"The physicians and staff of the Center for Digestive Health specialize in gastroenterology, which covers all aspects of the digestive system. Our specialty includes diagnostic endoscopic procedures and ultrasounds, liver disease studies, reflux diagnosis and management, and motility studies."

During the past decade, Center for Digestive Health conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 30 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 15 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Digestive Health" #1 sponsor was "Pfizer" with 7 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Celgene" with 3 trials sponsored and "Millennium Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Digestive Health" #1 collaborator was "Athersys, Inc" with 1 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Center for Digestive Health" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (12 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Center for Digestive Health" in a lesser frequency.

Most popular intervention types in "Center for Digestive Health" are "Drug" (43 trials), "Other" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "CP-690,550" (5 trials), "Etrolizumab" (5 trials), "vedolizumab" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Center for Digestive Health" are 45 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Digestive Health". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Center for Digestive Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Digestive Health, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".